Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R. Ito Y, et al. Among authors: kawa k. Clin Cancer Res. 2012 Aug 1;18(15):4183-90. doi: 10.1158/1078-0432.CCR-12-1064. Epub 2012 Jun 6. Clin Cancer Res. 2012. PMID: 22675173 Clinical Trial.
Prognostic factors for chronic active Epstein-Barr virus infection.
Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H; Japanese Association for Research on Epstein-Barr Virus and Related Diseases. Kimura H, et al. Among authors: kawa k. J Infect Dis. 2003 Feb 15;187(4):527-33. doi: 10.1086/367988. Epub 2003 Jan 28. J Infect Dis. 2003. PMID: 12599068 Free article.
Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R, Nakamura S, Suzumiya J, Ichimura K, Ichikawa M, Ogata K, Kura Y, Aikawa K, Teshima H, Sako M, Kojima H, Nishio M, Yoshino T, Sugimori H, Kawa K, Oshimi K; NK-cell Tumor Study Group. Suzuki R, et al. Among authors: kawa k. Cancer. 2005 Sep 1;104(5):1022-31. doi: 10.1002/cncr.21268. Cancer. 2005. PMID: 15999368 Free article.
NK-cell neoplasms in Japan.
Oshimi K, Kawa K, Nakamura S, Suzuki R, Suzumiya J, Yamaguchi M, Kameoka J, Tagawa S, Imamura N, Ohshima K, Kojya S, Iwatsuki K, Tokura Y, Sato E, Sugimori H; NK-cell Tumor Study Group. Oshimi K, et al. Among authors: kawa k. Hematology. 2005 Jun;10(3):237-45. doi: 10.1080/10245330400026162. Hematology. 2005. PMID: 16019472 Free article.
Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.
Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Okano M, et al. Among authors: kawa k. Am J Hematol. 2005 Sep;80(1):64-9. doi: 10.1002/ajh.20398. Am J Hematol. 2005. PMID: 16138335 Free article. Review.
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C, Mukai H, Takenaka K, Yoshino T, Tsuzuki T, Sugimori H, Kawa K, Kodera Y, Oshimi K; NK-cell Tumor Study Group. Suzuki R, et al. Among authors: kawa k. Bone Marrow Transplant. 2006 Feb;37(4):425-31. doi: 10.1038/sj.bmt.1705244. Bone Marrow Transplant. 2006. PMID: 16400344
Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.
Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K. Ishii E, et al. Among authors: kawa k. Int J Hematol. 2007 Jul;86(1):58-65. doi: 10.1532/IJH97.07012. Int J Hematol. 2007. PMID: 17675268
241 results